Home / Peptides

LL-37

Shop LL-37
Code ths10 applied at checkout

Also called: LL-37 , CAS: 154947-66-7, antimicrobial peptide, LL-37, human acetate, LL-37, human TFA

By The Health Stacks Research TeamUpdated September 5, 2026

LL-37 is a natural germ-fighting substance that your own body makes. It is a tiny chain of building blocks called amino acids. It is part of your body's first line of defense against germs.

Scientists call it a host-defense peptide. LL-37 works by poking holes in the outer skins of bacteria and by calming swelling in the body. Research groups study it to learn how the body fights infections and helps wounds heal.

It is one of a small group of peptides studied for immune support. Most of the research so far comes from lab and animal studies, not large human trials. Scientists are still learning how safe and useful it might be in people. It is sold only as a research chemical and is not approved as a medicine.

Research-stageEarly-stage — evidence so far is mostly cell, animal, or preliminary human studies. Not an approved medicine. Verified confidence80–100 — backed by strong, well-corroborated sources (peer-reviewed research, clinical guidelines). Our highest confidence tier.

Benefits

What LL-37 Helps With

The main themes across 131 research studies, in plain language.

Tissue & wound healing

Wound healing & tissue repair

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 30 underlying claims

Evidence suggests LL-37 promotes wound healing by stimulating cell migration, proliferation, and the formation of new blood vessels.

Research examplesBest source ↗

Chronic wound & ulcer support

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 6 underlying claims

Clinical studies suggest topical application of LL-37 may improve healing rates in chronic wounds, such as diabetic foot and venous leg ulcers.

Research examplesBest source ↗

Immune modulation

Immune system modulation

90/100Rated 90/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 24 underlying claims

Research points to LL-37 modulating immune responses by recruiting immune cells and regulating cytokines and chemokines.

Research examplesBest source ↗

Vitamin D pathway interaction

40/100Rated 40/100Source typeVendor / seller pageIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 2 underlying claims

Research confirms that Vitamin D3 upregulates the expression of LL-37, linking nutrient status to innate immune function.

Research examplesBest source ↗

Antimicrobial & antiviral

Broad-spectrum antimicrobial defense

90/100Rated 90/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 45 underlying claims

Research suggests LL-37 acts as a broad-spectrum antimicrobial agent, targeting bacteria, fungi, and viruses through membrane disruption and direct killing mechanisms.

Research examplesBest source ↗

Biofilm disruption & prevention

90/100Rated 90/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 11 underlying claims

Studies indicate LL-37 can disrupt established bacterial biofilms and prevent new biofilm formation, potentially enhancing antibiotic efficacy.

Research examplesBest source ↗

Antiviral activity

72/100Rated 72/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 5 underlying claims

Research indicates LL-37 exhibits antiviral effects against enveloped viruses, potentially by disrupting viral envelopes and triggering interferon responses.

Research examplesBest source ↗

Antibiotic resistance mitigation

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 5 underlying claims

Research highlights LL-37's potential for a lower risk of resistance development compared to traditional antibiotics, as well as synergy with existing drugs.

Research examplesBest source ↗

Gut barrier & mucosal defense

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 4 underlying claims

Research indicates LL-37 supports gut health by maintaining the integrity of the intestinal barrier and defending against pathogens.

Research examplesBest source ↗

Anti-inflammatory signaling

80/100Rated 80/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Studies suggest LL-37 helps regulate inflammation, including neutralizing bacterial endotoxins and modulating inflammatory cytokines.

Research examplesBest source ↗

Cellular defense & cytoprotection

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 8 underlying claims

Evidence suggests LL-37 interacts with cell membranes and signaling pathways to support cellular defense mechanisms and reduce toxicity to host cells.

Research examplesBest source ↗

Angiogenesis & vascular growth

72/100Rated 72/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 6 underlying claims

Studies suggest LL-37 stimulates the formation of new blood vessels, which is a key part of tissue repair and wound healing.

Research examplesBest source ↗

Neuroprotection & mitochondrial support

30/100Rated 30/100Source typeForum or blogIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 1 underlying claim

Preliminary research suggests LL-37 may offer neuroprotective effects through interactions with mitochondrial mechanisms.

Research examplesBest source ↗

Skin health & cosmetic appearance

30/100Rated 30/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 8 underlying claims

Research suggests LL-37 may play a role in skin rejuvenation, including anti-aging, anti-wrinkle, and repair processes.

Research examplesBest source ↗

Anticancer & cytotoxic activity

85/100Rated 85/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

In vitro research suggests LL-37 may induce cell death in certain cancer cell lines, though effects appear context-dependent.

Research examplesBest source ↗

Free: The Peptide Stack Cheat-Sheet

You just read the research on LL-37. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.

No spam. Unsubscribe anytime.

Safety

Known Side Effects

Adverse effects reported in the research and by community use.

  • Cell shrinkageMildReported in 9 sources 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources9Every claim links to the page it came from, and stronger sources rate higher. Full methodology →doi.orgdoi.orgdoi.orgdoi.org+5
  • Growth inhibitionModerateReported in 7 sources 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources7Every claim links to the page it came from, and stronger sources rate higher. Full methodology →doi.orgdoi.orgdoi.orgdoi.org+3
  • Growth arrestModerateReported in 2 sources 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →doi.orgdoi.org
  • Extended lag phaseMildReported in 4 sources 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →doi.orgdoi.orgdoi.orgdoi.org
  • High toxicity to human cellsSevere 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →pmc.ncbi.nlm.nih.gov
  • Susceptibility to proteolytic degradationModerateReported in 2 sources 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →pmc.ncbi.nlm.nih.govlink.springer.com
  • Induces inflammationMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →emedicine.medscape.com
  • Permanent nail deformitySevere 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →dermnetnz.org
  • Cytotoxicity towards human erythrocytes and keratinocytesModerate 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →link.springer.com
  • erythemaMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →emedicine.medscape.com
  • and telangiectasiaMild 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →emedicine.medscape.com

Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.

Get LL-37

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Shop LL-37
Code ths10 applied at checkout
Technical Details (sequence & mechanism — click to expand)

Mechanism of Action

LL-37 is the active 37-amino-acid fragment of the human cathelicidin antimicrobial peptide (CAMP gene) and a key effector of innate immunity. It directly kills bacteria and fungi at skin/mucosal/wound sites and modulates immunity (chemokine induction, TLR signaling, angiogenesis). It is an endogenous host-defense peptide; therapeutic analogs are in development but it is not an approved drug.

Evidence

Research Citations (10)

Every claim above traces back to a source you can check — here are 10 of them.

  • The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.

    Review2005 80/100Rated 80/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • LL-37 | C205H340N60O53 | CID 16198951 - PubChem

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Codelivery of 1α,25-dihydroxyvitamin D3 and CYP24A1 inhibitor VID400 by nanofiber dressings promotes endogenous antimicrobial peptide LL-37 induction

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Human cathelicidin peptide LL-37 compacts nucleic acids and alters neutrophil extracellular trap structure

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis

    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • The Human Host-Defense Peptide Cathelicidin LL-37 is a Nanomolar Inhibitor of Amyloid Self-Assembly of Islet Amyloid Polypeptide (IAPP)

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

Timeline

History & Milestones

Key moments in LL-37’s research and regulatory timeline — sourced and dated.

  1. The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm AgentPublicationMay 29, 2021
    Related:LL-37
    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  2. The human cathelicidin LL-37: a multifunctional peptidePublicationJan 1, 2005
    Related:LL-37
    80/100Rated 80/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

Wondering how LL-37 pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.